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Abstract
Background: Boar taint is the unpleasant odour and flavour of the meat of uncastrated male pigs that is primarily caused
by high levels of androstenone and skatole in adipose tissue. Androstenone is a steroid and its levels are mainly genetically
determined. Studies on androstenone metabolism have, however, focused on a limited number of genes. Identification
of additional genes influencing levels of androstenone may facilitate implementation of marker assisted breeding practices.
In this study, microarrays were used to identify differentially expressed genes and pathways related to androstenone
metabolism in the liver from boars with extreme levels of androstenone in adipose tissue.
Results: Liver tissue samples from 58 boars of the two breeds Duroc and Norwegian Landrace, 29 with extreme high
and 29 with extreme low levels of androstenone, were selected from more than 2500 individuals. The samples were
hybridised to porcine cDNA microarrays and the 1% most significant differentially expressed genes were considered
significant. Among the differentially expressed genes were metabolic phase I related genes belonging to the cytochrome
P450 family and the flavin-containing monooxygenase FMO1. Additionally, phase II conjugation genes including UDP-
glucuronosyltransferases  UGT1A5,  UGT2A1  and  UGT2B15, sulfotransferase STE, N-acetyltransferase NAT12  and
glutathione S-transferase were identified. Phase I and phase II metabolic reactions increase the water solubility of steroids
and play a key role in their elimination. Differential expression was also found for genes encoding 17beta-hydroxysteroid
dehydrogenases (HSD17B2, HSD17B4, HSD17B11 and HSD17B13) and plasma proteins alpha-1-acid glycoprotein (AGP)
and orosomucoid (ORM1). 17beta-hydroxysteroid dehydrogenases and plasma proteins regulate the availability of
steroids by controlling the amount of active steroids accessible to receptors and available for metabolism. Differences in
the expression of FMO1, NAT12, HSD17B2 and HSD17B13 were verified by quantitative real competitive PCR.
Conclusion: A number of genes and pathways related to metabolism of androstenone in liver were identified, including
new candidate genes involved in phase I oxidation metabolism, phase II conjugation metabolism, and regulation of steroid
availability. The study is a first step towards a deeper understanding of enzymes and regulators involved in pathways of
androstenone metabolism and may ultimately lead to the discovery of markers to reduce boar taint.
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Background
Boar taint is an off-odour and off-flavour in pig carcasses
that is primarily caused by high levels of 16-androstene
steroids [1] and/or skatole [2] in adipose tissue. Male pigs
used for meat production are normally castrated very early
in life to prevent boar taint in the meat. However, castra-
tion also removes the source of natural anabolic andro-
gens that stimulate lean growth and, as a result,
uncastrated males have improved feed efficiency and
greater lean yield of the carcass compared to barrows [3].
Detection of genetic factors influencing boar taint may
facilitate implementation of selective breeding practices
to produce pigs with little or no taint. Because of unfa-
vourable correlations between androstenone and other
sex steroids [4], a direct selection against high levels of
androstenone would result in decreased production of
testosterone and estrogens, with associated negative
effects on performance and sexual maturation. Therefore,
a comprehensive understanding of the complex genetic
system controlling boar taint is required before genetic
improvement can be achieved.
Androstenone (5α-androst-16-en-3-one) is produced in
the testis and is transported by blood to the salivary gland
where it functions as a pheromone to stimulate mating
stance in gilts [5]. It is metabolised in the liver, producing
α-androstenol and β-androstenol [6,7], and deficient deg-
radation may lead to the accumulation of androstenone
in adipose tissue. Skatole (3-methylindole) is produced
by the metabolism of tryptophan from the gut and is also
catabolised in liver. Diaz et al. [8] identified seven metab-
olites of skatole in pig liver microsomes. An increase in
levels of skatole in adipose tissue occurs in boars around
puberty, but not in barrows or sows, indicating that ska-
tole metabolism is regulated by testicular steroids [9,10].
Enzymes responsible for metabolism of androstenone
and skatole in liver have been identified but relatively few
genes have been investigated. Several studies have shown
that 3β-hydroxysteroid dehydrogenase (3β-HSD) is
involved in androstenone metabolism, with low mRNA,
protein and enzyme expression levels correlated to high
androstenone levels in adipose tissue [6,11,12]. Cyto-
chrome P450 2E1 (CYP2E1) is involved in metabolism of
skatole [13,14] and deficient CYP2E1 induction is sug-
gested to be a major cause of high levels of skatole in adi-
pose tissue [10]. A relationship between metabolism of
androstenone and skatole in liver has been observed [9],
with evidence to suggest that androstenone blocks
CYP2E1 induction by skatole [10]. Sulfotransferase
enzymes including SULT2A1, SULT2B1 and SULT1A1 are
associated with metabolic clearance of androstenone and
skatole since they are known to conjugate steroid hor-
mones and drugs into more water soluble compounds
that facilitates excretion [12,15-20].
Although both androstenone and skatole are responsible
for boar taint, androstenone seems to be the biggest prob-
lem in the Duroc and Norwegian Landrace populations
[21]. Levels of androstenone are also predominantly
genetically determined whereas levels of skatole are more
heavily influenced by feeding and environmental factors.
Levels of androstenone will be a function of both produc-
tion in testes and elimination in liver. We have previously
studied differentially expressed genes related to the pro-
duction of androstenone in boar testis [17], and the objec-
tive of this study was to investigate global gene expression
profiles related to the degradation of androstenone in pig
livers. Microarray technology was used to obtain gene
expression profiles from liver samples of Duroc (D) and
Norwegian Landrace (NL) boars with extreme high or low
levels of androstenone in adipose tissue. These samples
were hybridised together with a common reference sam-
ple to cDNA microarrays representing approximately
20,000 porcine gene transcripts. A total of 29 animals
were selected from each group, resulting in a total of 116
arrays. A subset of the differentially expressed genes was
verified using a quantitative PCR-based method.
Results
Porcine cDNA microarrays were used to obtain global
gene expression profiles in liver tissues sampled from 58
D and 58 NL boars with extreme high and low levels of
androstenone. Average levels of androstenone were 11.57
± 3.2 ppm for D high (DH) and 0.37 ± 0.17 ppm for D
low (DL) boars. Average levels of androstenone were 5.95
± 2.04 ppm for NL high (NLH) and 0.14 ± 0.04 ppm for
NL low (NLL) boars. Linear models were used to identify
significantly differentially expressed genes and the top 1%
(269) most significant genes were subsequently inspected
as possible candidate genes affecting androstenone levels
(See additional file 1: Microarray results for Duroc, addi-
tional file 2: Microarray results for Norwegian Landrace).
The top 100 genes of D and NL are presented in table 1
and 2, respectively. Among the 269 affected genes, 25
were found to be in common for the two breeds and
expression differences were generally more significant in
D compared to NL.
Testing for overrepresentation of gene ontology (GO)
terms among the 269 affected genes was performed rela-
tive to the global representation of GO terms on the
microarray. A majority of the significant genes were
related to oxidoreductase activities, glucuronosyltrans-
ferase activity and the binding of iron ion, haem, DNA
and oxygen (Figure 1). Additionally, cellular metabolic
process pathways such as amino acid metabolism and
catabolism, electron transport and inflammatory
response were overrepresented (Figure 2). Furthermore,
the genes were classified according to their cellular com-
ponent ontology (See additional file 3: Gene ontologyBMC Veterinary Research 2008, 4:29 http://www.biomedcentral.com/1746-6148/4/29
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Table 1: Top 100 genes identified in Duroc.
ID Name gene_id FoldChange adj.P.Val
103725 Cytochrome P450 2C49 (CYP2C49) NM_214420.1 1.227 8.26e-24
104194 Cytochrome P450 2C49 (CYP2C49) NM_214420.1 0.853 4.98e-20
102872 Glycine-N-acyltransferase (GLYAT) NM_201648.1 1.113 1.27e-19
103265 Cytochrome P450 2C49 (CYP2C49) NM_214420.1 1.480 4.76e-18
103234 Hepatic flavin-containing monooxygenase (FMO) (FMO1) NM_214064.1 1.179 2.28e-17
206700 Cytochrome P450 2C49 (CYP2C49) NM_214420.1 1.099 2.71e-16
102682 Serum amyloid P component (APCS) NM_213887.1 1.294 2.71e-16
102284 Sterile alpha motif domain containing 8 (Samd8) NM_026283.2 0.969 3.44e-16
102668 Hepatic flavin-containing monooxygenase (FMO) (FMO1) NM_214064.1 1.271 8.01e-16
100748 Regulatory factor X domain containing 2 (RFXDC2) NM_022841.3 0.594 7.47e-14
206864 Similar to Alcohol dehydrogenase 6 (LOC523510) XM_601810.2 -0.925 3.49e-13
102390 Cytochrome P450 2C49 (CYP2C49) NM_214420.1 1.152 5.05e-13
102098 Carnitine O-octanoyltransferase (CROT) NM_021151.2 0.886 5.30e-13
102991 Cytochrome P450. family 2. subfamily E. polypeptide 1 (CYP2E1) NM_214421.1 -1.040 2.17e-12
216026 216026 -0.728 3.72e-12
102413 Small nuclear RNA activating complex. polypeptide 1. 43 kDa (SNAPC1) NM_003082.2 0.994 4.84e-12
103432 103432 0.527 2.07e-11
210250 Metallothionein (MT1A) NM_001001266.1 -0.965 3.09e-11
103062 FKBP1A-like (LOC654323) NM_001038000.1 -1.078 3.09e-11
103279 Orosomucoid 1 (ORM1) NM_000607.1 -0.947 3.99e-11
103021 Hydroxysteroid (17-beta) dehydrogenase 13 (HSD17B13) NM_178135.2 -0.869 6.10e-11
201488 201488 0.462 1.08e-10
100575 17beta-estradiol dehydrogenase (HSD17B4) NM_214306.1 0.452 1.24e-10
100723 Aspartate aminotransferase (GOT2) NM_213928.1 0.493 3.71e-10
103194 Alpha-1 acid glycoprotein (AGP) XM_585370.2 -0.932 4.52e-10
202082 Family with sequence similarity 10. member A4 (FAM10A4) NR_002183.1 0.424 6.45e-10
100724 Phytanoyl-CoA hydroxylase (PHYH) NM_006214.3 0.518 8.69e-10
210077 Cytochrome P450 2C49 (CYP2C49) NM_214420.1 0.872 9.95e-10
101277 Estrogen sulfotransferase (STE) NM_213992.1 0.557 1.45e-09
216031 Insulin-like-growth factor 2 (IGF2) NM_213883.1 -0.687 1.88e-09
210204 Similar to HLA class I histocompatibility antigen, A-11 alpha chain precursor (LOC642049) XM_936199.1 -0.591 1.88e-09
103031 Type I iodothyronine deiodinase (DIO1) NM_001001627.1 0.499 2.85e-09
210252 Sarcosine dehydrogenase (SARDH) NM_007101.2 -0.273 3.55e-09
102976 Similar to UDP-glucuronosyltransferase 2B15 precursor (UDPGT) (HLUG4) (LOC653180) XM_931558.1 0.623 4.69e-09
201274 Sorbitol dehydrogenase (SORD). mRNA NM_003104.3 0.523 5.70e-09
103801 Similar to Sorbitol dehydrogenase (L-iditol 2-dehydrogenase) (LOC650043) XM_939131.1 0.452 1.83e-08
204461 Glycine-N-acyltransferase (GLYAT). nuclear gene encoding mitochondrial protein NM_005838.2 0.370 2.47e-08
102538 102538 0.746 2.65e-08
204863 Hydroxysteroid (17-beta) dehydrogenase 13 (HSD17B13) NM_178135.2 -0.630 3.89e-08
101843 Abhydrolase domain containing 3 (ABHD3) NM_138340.3 0.370 9.87e-08
215880 Transcription elongation factor B (SIII). polypeptide 3 (110 kDa. elongin A) (TCEB3) NM_003198.1 -0.612 9.87e-08
200322 Taxilin beta (TXLNB) NM_153235.2 0.385 9.87e-08
210206 Metallothionein (MT1A) NM_001001266.1 -0.536 1.25e-07
201503 Carboxylesterase (CES3) NM_214246.1 0.472 1.44e-07
202070 202070 0.485 1.57e-07
102106 102106 0.335 1.86e-07
206300 Protein tyrosine phosphatase type IVA. member 1 (PTP4A1) NM_003463.3 0.337 2.01e-07
103047 Similar to mouse 2310016A09Rik gene (LOC134147) NM_138809.3 0.456 2.01e-07
204653 FKBP1A-like (LOC654323) NM_001038000.1 0.256 2.06e-07
103327 UDP glucuronosyltransferase 1 family, polypeptide A5 (UGT1A5) NM_019078.1 0.264 2.42e-07
102469 Chromosome 1 open reading frame 128 (C1orf128) NM_020362.2 0.190 2.42e-07
201919 FKBP1A-like (LOC654323) NM_001038000.1 0.303 2.53e-07
103349 Kininogen 1 (KNG1) NM_000893.2 0.428 3.03e-07
103940 UDP glucuronosyltransferase 1 family, polypeptide A5 (UGT1A5) NM_019078.1 0.191 4.03e-07
204455 Ornithine carbamoyltransferase (OTC) NM_000531.3 0.357 4.61e-07
212598 L1 cell adhesion molecule (L1CAM) NM_024003.1 -0.167 4.72e-07
207639 207639 0.383 4.83e-07
200534 200534 0.388 4.89e-07
102183 Protein tyrosine phosphatase type IVA. member 1 (PTP4A1) NM_003463.3 0.360 5.72e-07BMC Veterinary Research 2008, 4:29 http://www.biomedcentral.com/1746-6148/4/29
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(GO) results for the cellular component ontology in
Duroc, additional file 4: Gene ontology (GO) results for
the cellular component ontology in Norwegian Lan-
drace). For D, cytoplasm, microsomes and endoplasmatic
reticulum were among the important cellular compo-
nents, none of the cellular components reached the level
of significance, i.e. had more than 10 significant genes
related to the CC terms.
To validate the microarray results, a real competitive PCR
(rcPCR) approach was applied to five selected genes: Fla-
vin-containing monooxygenase 1 (FMO1), transcription
factor GATA-4 (GATA4), 17β-hydroxysteroid dehydroge-
nase 13 (HSD17B13), 17β-hydroxysteroid dehydrogenase
2 (HSD17B2) and N-acetyltransferase 12 (NAT12). Their
expression levels were normalised to the housekeeping
gene transferrin receptor (TFRC). Differential expression
of FMO1, HSD17B13, HSD17B2 and NAT12 was con-
firmed in both D and NL breeds (p < 0.05) while altered
expression of GATA4 was not found in either of the two
breeds (Figure 3).
206424 Similar to transcription elongation factor B polypeptide 3 binding protein 1 isoform 1 
(LOC533427)
XM_612827.2 0.265 6.41e-07
103306 Tryptophan 2.3-dioxygenase (TDO2) NM_005651.1 0.443 6.41e-07
104125 Sorbitol dehydrogenase (SORD) NM_003104.3 0.428 7.73e-07
102709 102709 0.444 7.76e-07
100472 S-adenosylhomocysteine hydrolase (AHCY) NM_001011727.1 0.321 8.64e-07
206129 206129 -0.484 8.86e-07
102624 Ornithine carbamoyltransferase (OTC) NM_000531.3 0.393 8.86e-07
213735 Metallothionein (MT1A) NM_001001266.1 0.422 1.01e-06
102836 Carboxylesterase (CES3) NM_214246.1 0.563 1.10e-06
201162 FKBP1A-like (LOC654323) NM_001038000.1 0.268 1.42e-06
201961 201961 0.293 1.42e-06
216074 Metallothionein (MT1A) NM_001001266.1 -0.772 1.64e-06
207278 207278 0.282 1.67e-06
101716 101716 0.328 1.75e-06
204421 Meiosis-specific nuclear structural 1 (MNS1) NM_018365.1 0.364 1.99e-06
103156 103156 0.333 2.05e-06
103376 Hydroxysteroid (17-beta) dehydrogenase 13 (HSD17B13) NM_178135.2 -0.497 2.38e-06
100064 Similar to UDP-galactoseN-acetylgalactosamine-alpha-R beta 1,3-galactosyltransferase 
(LOC645551)
XM_928571.1 0.159 2.43e-06
204950 Abhydrolase domain containing 3 (ABHD3) NM_138340.3 0.236 2.43e-06
204048 Suppression of tumorigenicity 13 (colon carcinoma) (Hsp70 interacting protein) (ST13) NM_003932.3 0.379 2.74e-06
204867 204867 0.308 2.95e-06
207963 207963 0.254 3.08e-06
200952 200952 0.236 3.08e-06
103294 Similar to Mob4B protein (MGC124888) NM_001033891.1 0.369 3.79e-06
208427 RAR-related orphan receptor A (RORA) NM_134262.1 0.246 4.25e-06
208058 FKBP1A-like (LOC654323) NM_001038000.1 0.247 4.48e-06
205360 FLJ20105 protein (FLJ20105) NM_017669.2 0.278 4.73e-06
207838 3-hydroxymethyl-3-methylglutaryl-Coenzyme A lyase (hydroxymethylglutaricaciduria) 
(HMGCL)
NM_000191.2 0.156 4.78e-06
101413 Replication protein A3. 14 kDa (RPA3) NM_002947.3 0.253 5.25e-06
103180 T-complex 1 (TCP1) NM_001008897.1 0.310 5.69e-06
202298 202298 0.262 5.73e-06
100384 Alpha-methylacyl-CoA racemase (AMACR) NM_014324.4 0.394 6.68e-06
103434 Acyl-Coenzyme A oxidase 1, palmitoyl (ACOX1) NM_004035.5 0.368 7.11e-06
202477 Hypothetical LOC505518 (LOC505518) XM_581816.2 0.240 7.42e-06
102858 102858 0.587 7.52e-06
103058 103058 0.381 7.67e-06
211612 Gamma-aminobutyric acid (GABA) A receptor. alpha 3 (GABRA3) NM_000808.2 -0.135 8.97e-06
201347 HRAS-like suppressor 3 (HRASLS3) NM_007069.1 0.352 8.97e-06
102840 Sorbitol dehydrogenase (SORD) NM_003104.3 0.270 8.97e-06
201105 COP9 constitutive photomorphogenic homolog subunit 2 (Arabidopsis) (COPS2) NM_004236.1 0.242 9.06e-06
201848 Kinesin family member C1 (KIFC1) NM_002263.2 0.274 9.06e-06
Gene expression profiles were identified in Limma using empirical Bayes moderated t-statistics. Fold change and statistical significance is shown 
(FDR-adjusted p-values). The clone names refer to hits to pig, human, mouse or bovine sequences. Some genes are represented by several different 
clones on the array and may therefore show up more than once in the table, while others have no hits to the abovementioned species.
Table 1: Top 100 genes identified in Duroc. (Continued)BMC Veterinary Research 2008, 4:29 http://www.biomedcentral.com/1746-6148/4/29
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Table 2: Top 100 genes identified in Norwegian Landrace.
ID Name gene_id FoldChange adj.P.Val
206864 Similar to Alcohol dehydrogenase 6 (LOC523510) XM_601810.2 -0.730 1.07e-13
204853 204853 -0.441 2.39e-13
209551 Isochorismatase domain containing 1 (ISOC1) NM_016048.1 -0.403 3.28e-13
103021 Hydroxysteroid (17-beta) dehydrogenase 13 (HSD17B13) NM_178135.2 -0.900 3.28e-13
204863 Hydroxysteroid (17-beta) dehydrogenase 13 (HSD17B13) NM_178135.2 -0.730 3.78e-13
209525 Zinc finger protein 471 (ZNF471) NM_020813.1 -0.335 1.69e-12
102789 102789 -0.364 1.69e-12
204725 204725 -0.367 1.69e-12
103376 Hydroxysteroid (17-beta) dehydrogenase 13 (HSD17B13) NM_178135.2 -0.589 2.41e-12
205190 Similar to heterogeneous nuclear ribonucleoprotein C isoform b (LOC654074) XM_945342.1 0.249 7.01e-12
204302 Aldehyde oxidase 1 (AOX1) NM_001159.3 -0.481 9.60e-12
204466 204466 -0.345 1.20e-11
203752 203752 -0.274 1.52e-11
206901 Non-histone protein HMG1 (LOC445521) NM_001004034.1 -0.286 5.34e-11
218781 KIAA1344 (KIAA1344) NM_020784.1 0.280 5.34e-11
216031 Insulin-like-growth factor 2 (IGF2) NM_213883.1 -0.847 5.34e-11
213651 213651 -0.437 9.01e-11
215880 Transcription elongation factor B (SIII). polypeptide 3 (110 kDa. elongin A) (TCEB3) NM_003198.1 -0.797 9.45e-11
204619 Cytochrome b-5 (CYB5) NM_001001770.1 -0.458 9.45e-11
204520 204520 -0.290 1.45e-10
103177 Cytochrome b-5 (CYB5) NM_001001770.1 -0.489 2.06e-10
102774 Non-histone protein HMG1 (LOC445521) NM_001004034.1 -0.302 3.48e-10
204081 204081 -0.251 3.48e-10
100528 ATP synthase. H+ transporting. mitochondrial F0 complex. subunit F6 (ATP5J) NM_001003703.1 0.250 3.55e-10
211561 KIAA0427 (KIAA0427) NM_014772.1 0.263 4.63e-10
209674 209674 0.269 7.12e-10
208386 Dual specificity phosphatase 12 (DUSP12) NM_007240.1 -0.318 7.12e-10
207228 Small nuclear ribonucleoprotein polypeptide E (SNRPE) NM_003094.2 0.252 7.37e-10
219297 Purine-rich element binding protein A (PURA) NM_005859.3 0.499 8.70e-10
218205 SMC1 structural maintenance of chromosomes 1-like 1 (yeast) (SMC1L1) NM_006306.2 0.300 1.11e-09
103194 Alpha-1 acid glycoprotein (AGP) XM_585370.2 -1.071 1.16e-09
219538 219538 0.352 1.67e-09
201622 Hypothetical protein LOC285016 (LOC285016) NM_001002919.1 -0.417 1.99e-09
217117 Amyloid beta (A4) precursor protein-binding. family B. member 3 (APBB3) NM_006051.2 0.294 2.38e-09
102677 4-aminobutyrate aminotransferase (ABAT) NM_000663.2 0.288 2.38e-09
216026 216026 -0.840 2.51e-09
216643 Leupaxin (Lpxn) NM_134152.1 0.271 2.93e-09
205721 205721 -0.256 3.02e-09
202919 202919 0.272 3.02e-09
220257 Similar to 60S ribosomal protein L39 (LOC651724) XM_940942.1 0.273 3.10e-09
103136 Mitochondrial translational initiation factor 2 (MTIF2) NM_001005369.1 -0.250 3.35e-09
201942 201942 -0.286 4.06e-09
216638 216638 0.304 4.06e-09
204605 Similar to Maltase-glucoamylase, intestinal (LOC642103) XM_936233.1 -0.234 4.12e-09
208567 208567 -0.307 4.71e-09
103361 Phenylalanine hydroxylase (PAH) NM_000277.1 -0.627 5.15e-09
202659 FKBP1A-like (LOC654323) NM_001038000.1 -0.312 5.49e-09
207982 La ribonucleoprotein domain family. member 4 (LARP4) NM_052879.3 -0.247 5.63e-09
204513 Deoxyribonuclease II (DNASE2) NM_214196.1 -0.255 5.73e-09
206370 Syndecan binding protein (syntenin) (SDCBP) NM_001007068.1 -0.208 6.33e-09
214304 Heat shock transcription factor 1 (HSF1) NM_005526.1 0.331 7.28e-09
103062 FKBP1A-like (LOC654323) NM_001038000.1 -1.046 7.37e-09
200969 Family with sequence similarity 70. member A (FAM70A) NM_017938.2 0.424 7.37e-09
206063 Chromosome 14 open reading frame 43 (C14orf43) NM_194278.2 -0.230 8.05e-09
206129 206129 -0.447 1.10e-08
206577 Leukemia inhibitory factor receptor (LIFR) NM_002310.3 -0.265 1.39e-08
103378 Similar to Putative steroid dehydrogenase KIK-I (LOC508455) XM_585231.2 -0.314 1.49e-08
204838 FKBP1A-like (LOC654323) NM_001038000.1 -0.309 1.49e-08
104413 Pyruvate carboxylase (PC) NM_214349.1 0.246 1.49e-08BMC Veterinary Research 2008, 4:29 http://www.biomedcentral.com/1746-6148/4/29
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Discussion
Elevated levels of androstenone in adipose tissue can
result from both increased biosynthesis in the testes and
deficient metabolism in liver. We have previously con-
ducted a microarray experiment investigating gene expres-
sion profiles in the testes of boars with extreme levels of
androstenone, and in this study we have examined gene
expression profiles in the liver of some representatives
from that study along with new individuals. Liver metab-
olism can be divided into phase I and phase II reactions
[22]. Phase I metabolism involves oxidation and hydrox-
ylation reactions that make the substrate more water sol-
uble. Phase II conjugation reactions further increase
hydrophilicity by adding polar groups. As a result of these
metabolic reactions, compounds including endogenous
steroids, fatty acids and drugs are inactivated and elimi-
nated. We have identified a number of differentially
expressed genes that function in pathways affecting both
phase I and phase II reactions involved in metabolism of
androstenone in the liver.
Phase I metabolism
The most significantly differentially expressed gene
involved in phase I oxidation reactions was cytochrome
P450 2C49 (CYP2C49). This gene is a member of the
CYP2C family [23] and genes of this family encode
monooxygenases that catalyse several reactions involved
in the metabolism of drugs and endogenous compounds.
219405 Coiled-coil domain containing 42 (CCDC42) NM_144681.1 0.447 1.49e-08
209512 209512 -0.310 1.72e-09
221025 221025 0.446 1.74e-08
200362 Chromosome 3 open reading frame 43, transcript variant 1 (C3orf43) XM_173087.5 -0.199 1.88e-08
206386 206386 -0.262 2.65e-08
211845 Alanyl-tRNA synthetase domain containing 1 (AARSD1) NM_025267.2 0.250 3.31e-08
208761 Ring finger protein 148 (RNF148) NM_198085.1 -0.189 3.31e-08
209449 Similar to Zinc finger CCCH-type domain containing protein 11A transcript variant 3 
(LOC441155)
XM_930970.1 -0.237 3.31e-08
205142 Bone morphogenetic protein receptor, type IA (BMPR1A) NM_004329.2 -0.340 3.31e-08
203722 203722 -0.217 3.32e-08
103279 Orosomucoid 1 (ORM1) NM_000607.1 -0.999 3.32e-08
101898 Bifunctional apoptosis regulator (BFAR) NM_016561.1 -0.189 3.32e-08
104972 Cyclin-dependent kinase inhibitor 3 (CDKN3) NM_214320.1 0.364 3.45e-08
202997 202997 -0.270 3.45e-08
102991 Cytochrome P450. family 2. subfamily E. polypeptide 1 (CYP2E1) NM_214421.1 -1.079 3.68e-08
208187 Early growth response 3 (EGR3) NM_004430.2 0.378 3.77e-08
205347 Histone H3.3A (H3F3A) NM_213930.1 -0.237 3.77e-08
203762 Zinc finger protein 7 (KOX 4. clone HF.16) (ZNF7) NM_003416.1 -0.234 4.37e-08
102955 L-kynurenine 3-monooxygenase Fpk (KMO) NM_214076.1 -0.294 4.81e-08
212532 TBC1 domain family. member 10B (TBC1D10B) NM_015527.2 0.231 4.99e-08
206466 Similar to glycosyltransferase-like domain containing 1 isoform a (LOC534677) XM_871633.1 -0.299 5.15e-08
104900 Cullin 4A (CUL4A). transcript variant 1 NM_001008895.1 0.349 5.59e-08
208650 FKBP1A-like (LOC654323) NM_001038000.1 -0.214 5.83e-08
205233 5'-3' exoribonuclease 2 (XRN2) NM_012255.3 0.217 5.99e-08
102672 Cytochrome b-5 (CYB5) NM_001001770.1 -0.528 6.21e-08
101034 Programmed cell death 6 interacting protein (PDCD6IP) NM_013374.3 -0.247 6.21e-08
206253 Cyclin-dependent kinase 6 (CDK6) NM_001259.5 -0.260 6.21e-08
209516 209516 -0.208 6.21e-08
100909 Myeloid-associated differentiation marker (MYADM) NM_001020819.1 -0.239 7.42e-08
205225 Family with sequence similarity 80, member B (FAM80B) NM_020734.1 0.247 7.42e-08
200683 200683 -0.302 7.64e-08
208724 Dickkopf-like 1 (soggy) (DKKL1) NM_014419.3 0.275 7.64e-08
218253 Mesoderm induction early response 1, family member 2 (MIER2) NM_017550.1 0.265 7.97e-08
209231 Heparin binding protein (HBP15/L22) NM_213987.1 -0.343 8.00e-08
104000 Ribosomal protein L39 (RPL39) NM_001000.2 0.264 8.37e-08
205725 205725 -0.208 8.73e-08
102726 Complement factor I (CFI) NM_000204.1 -0.380 8.77e-08
100609 Proline rich 13 (PRR13) NM_001005355.1 0.267 9.03e-08
104957 Succinyl-CoA:alpha-ketoacid coenzyme A transferase (OXCT) NM_213938.1 0.392 9.03e-08
216727 216727 -0.287 9.12e-08
200320 Ubiquitin specific peptidase 32 (USP32) XM_939750.1 0.439 9.28e-08
Gene expression profiles were identified in Limma using empirical Bayes moderated t-statistics. Fold change and statistical significance is shown 
(FDR-adjusted p-values). The clone names refer to hits to pig, human, mouse or bovine sequences. Some genes are represented by several different 
clones on the array and may therefore show up more than once in the table, while others have no hits to the abovementioned species.
Table 2: Top 100 genes identified in Norwegian Landrace. (Continued)BMC Veterinary Research 2008, 4:29 http://www.biomedcentral.com/1746-6148/4/29
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Different CYP2C isoforms show some cross reactivity
towards substrates which makes it difficult to differentiate
CYP2C activities, and substrate specificity for CYP2C49 is
not known [24]. In our study, CYP2C49 transcripts were
shown to have a significant up-regulation in boars with
high levels of androstenone in both D and NL lines (DH
and NLH) but differences were clearly most prominent in
the D breed.
Another member of the cytochrome P450 superfamily,
that was differentially expressed in our study, is cyto-
chrome P450 2E1 (CYP2E1). In contrast to expression of
the CYP2C49 gene, CYP2E1 showed a down-regulation in
DH and NLH boars. CYP2E1  encodes an enzyme that
metabolises many endogenous and exogenous substrates
such as alcohols, ketones and drugs [24]. Androstenone
has been shown to block skatole induced expression of
CYP2E1 in pig hepatocytes and to inhibit activity of
CYP2E1 in porcine liver microsomes [10,25]. Liver
metabolism of skatole also involves this gene and enzyme
[13,14,26-28], and the observed pubertal increase in ska-
tole levels has been attributed to the inhibition of CYP2E1
by the sex steroids androstenone and 17β-estradiol [25].
This is the first study, however, to show gene expression
differences for CYP2E1 in relation to androstenone.
Cytochrome P450 member 2A19 (CYP2A19), which is the
pig ortholog of human CYP2A6, catalyses 7-hydroxylation
of coumarin in pigs [26], in addition to being involved in
skatole metabolism [29]. In this study, CYP2A19 was sig-
nificantly down-regulated in DH boars. Gene expression
differences in animals with high and low androstenone
levels have not previously been reported for porcine
CYP2A19, however its protein expression has been shown
to be inhibited by androstenone [30]. Diaz and Squires
[26] found that both CYP2A6 protein content and its
enzymatic activity were negatively correlated with skatole
levels in adipose tissue. In contrast, results presented by
Terner et al. [28] indicate that the CYP2A6 enzyme is not
important for metabolism of skatole in primary cultured
porcine hepatocytes.
Two other members of the cytochrome P450 family,
CYP27A1 and CYP2C33, were also up-regulated in DH.
CYP27A1 is a multifunctional enzyme that oxygenates
cholesterol, bile acids and vitamin D. It has not previously
been identified as a candidate gene associated with
androstenone, but it is regulated by other sex steroids in
human cells [31]. CYP2C33 belongs to the same sub-fam-
ily as CYP2C49, but its function has yet to be described in
the literature. Like the CYP2C49  gene,  CYP2C33  was
Figure 1BMC Veterinary Research 2008, 4:29 http://www.biomedcentral.com/1746-6148/4/29
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found to be up-regulated in DH and NLH boars. The dif-
ferential expression of CYP2A19, CYP27A1 and CYP2C33
in D and not NL boars might suggest that more genes are
involved in phase I reactions in D. This is supported by a
high number of oxidoreductase pathways significant in D
(figure 1). Monooxygenase reactions are, however, clearly
important in both breeds according to our gene ontology
results (figure 1). Down-regulation of CYP2E1  and
CYP2A19 might suggest a different role for these genes
compared to the up-regulated CYP2C18, CYP2C33 and
CYP27A1.
Our study implicates another class of genes involved in
phase I oxidation reactions, namely the flavin-containing
monooxygenases (FMOs). The FMO family of enzymes
converts lipophilic compounds into more polar metabo-
Figure 2BMC Veterinary Research 2008, 4:29 http://www.biomedcentral.com/1746-6148/4/29
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lites and decreases activity of the compounds, a similar
activity to that of the cytochrome P450s [32]. Microarray
expression results show that flavin-containing monooxy-
genase 1 (FMO1) was significantly up-regulated in DH in
the microarray results. The expression pattern in DH boars
was confirmed by rcPCR and the rcPCR analysis also
revealed that FMO1 was up-regulated in NLH boars. As
shown in figure 2, the fold change in NLH was only half
of DH, which might explain why this gene was not found
to be significantly differentially expressed in the microar-
ray results. Regulation of FMO involves sex steroids. In
male mice, castration was reported to increase FMO1
expression [33], while in rats the opposite effect has been
shown, with positive regulation of FMO by testosterone
and negative by estradiol [34]. The monooxygenase activ-
ity of FMO1 in addition to its regulation by steroid hor-
mones makes it an interesting candidate gene for boar
taint.
Phase II metabolism
Phase I oxidation reactions of androstenone by enzymes
including cytochrome P450s and FMOs are often fol-
lowed by phase II conjugation reactions that are catalysed
by glucuronosyltransferases, sulfotransferases, acetyl-
transferases and glutathione S-transferases [22]. Through
the addition of polar moieties, these enzymes increase
substrate solubility. Conjugation reactions are an impor-
tant means of excreting steroid hormones and other com-
pounds, these reactions have also been proposed to keep
inactive steroids easily available in cells. The hydroxyster-
oid sulfotransferases SULT2A1 and SULT2B1 have been
associated with androstenone levels in previous studies
[12,15-17]. These genes were not found to be significantly
differentially expressed in our study, however the estrogen
sulfotransferase STE (SULT2E1) was found to be up-regu-
lated in DH boars and down-regulated in NLH boars. A
previous microarray study performed by our group
showed an up-regulation of CYP19 gene expression in the
testis of D and NL boars with high androstenone levels
[17]. These genes encode enzymes biosynthesising estro-
gens and might explain why an estrogen conjugation
enzyme is differentially expressed in livers of the same
pigs. Furthermore, boars secrete large quantities of estro-
gens from the testis [35], and both fat and plasma estro-
gen levels have previously been shown to be highly
correlated with levels of androstenone in adipose tissue
[36,37].
Figure 3BMC Veterinary Research 2008, 4:29 http://www.biomedcentral.com/1746-6148/4/29
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Phase II conjugation by glucuronidation is another major
pathway of liver elimination of endogenous and exoge-
nous compounds, and in D this molecular function was
significantly overrepresented. It is catalysed by uridine
diphospho-glucuronosyltransferases (UGTs) which trans-
fer glucuronic acid to substrates to increase solubility [38].
The UGTs have been divided into two subfamilies, the
UGT1s and the UGT2s, and in this study the family mem-
ber UGT1A5 was found to be up-regulated in DH boars.
Furthermore, a transcript similar to UGT2B15 was up-reg-
ulated in D and a transcript similar to UGT2A1 was down-
regulated in NLH. UGT2B15 has been shown to conjugate
several androgens in humans [38], whereas UGT1A5 has
been found to be catalytically active against some exoge-
nous compounds [39]. UGT2A1 contributes to glucuroni-
dation of steroids and phenolic compounds in olfactory
tissue and has been found to eliminate odourants [40].
The UGT family of conjugation enzymes have previously
been associated with the androstenone metabolites α-
androstenol and β-androstenol [41,42].
N-acetyltransferases (NATs) are another family of conju-
gation enzymes and act by transferring the acetyl group of
acetyl coenzyme A to aromatic amines to increase their
water solubility [22]. NAT type 12 (NAT12) was found to
be up-regulated in NLH based on the microarray results
and this was verified by rcPCR. The rcPCR results also
revealed an up-regulation in DH boars. Androgens have
been shown to increase expression of NAT type 1 in
human cancer cells [43], but the enzyme family has not
previously been associated with levels of androstenone.
Tryptophan, the precursor of skatole, contains an aro-
matic, suggesting a role for this family of conjugation
enzymes in the control of skatole levels, possibly through
regulation by steroid hormones.
Glutathione S-transferases (GSTs) are functionally diverse
enzymes mostly known to catalyse conjugation reactions
of endogenous substances, haem, fatty acids, xenobiotics
and products of oxidative processes [44]. They have also
been implicated in the intracellular transport of steroids
to their site of action [44]. In this study, a glutathione S-
transferase gene was found to be down-regulated in NLH.
The gene is described in the database as LOC396850. We
have previously described up-regulation of two GST
genes, GSTO1 and MGST1, in association with testicular
androstenone levels [17], and here we additionally pro-
pose a role for glucuronidation in liver metabolism.
Expression of phase II metabolic genes in D and NL pigs
suggest breed specific mechanisms. We found differential
expression of a GST variant (LOC396850) in NL but not D
boars, up-regulation of STE in DH but down-regulation in
NLH, and up-regulation of two UGT  genes in DH but
down-regulation of another family member in NLH.
Breed specific phase II mechanisms for these breeds are in
agreement with our previous finding for the protein
SULT2B1 [12].
Regulation of steroid availability
17β-hydroxysteroid dehydrogenases (17β-HSDs) regulate
the availability of androgens and estrogens in tissues by
catalysing interconvertion of active and inactive forms of
steroids [45]. They do so by regulating the occupancy of
steroid nuclear hormone receptors like androgen receptor,
estrogen receptor and progesterone receptor [46]. Gene
expression of 17β-HSD in porcine liver has been shown to
be negatively associated with levels of androstenone in
adipose tissue [37]. In a previous study, we found that the
HSD17B4 gene was significantly up-regulated in testicle
samples from DH and NLH [17], and in this study
HSD17B4 was up-regulated in the liver of DH boars. Addi-
tionally, we found that HSD17B2 was down-regulated in
DH and that the isoform HSD17B13 was down-regulated
in both DH and NLH. Differential expression of both
HSD17B2 and HSD17B13 was verified by rcPCR, which
also showed significant down-regulation of HSD17B2 in
NLH boars. The HSD17B2 enzyme catalyses the intercon-
version of testosterone and androstenedione, as well as
estradiol and estrone [47]. The function of isoform
HSD17B13, also known as short-chain dehydrogenase/
reductase 9, has yet to be described but its expression has
been characterised in human liver [48]. The short-chain
dehydrogenase/reductase 8 gene (DHRS8), also known as
HSD17B11, was found to be down-regulated in NLH
boars. HSD17B11 is involved in androgen metabolism
[49] and we previously found this gene to be down-regu-
lated in the testis of DH boars [17]. The HSDs belong to
two superfamilies: the short-chain dehydrogenase/reduct-
ases (SDRs) and the aldo-keto reductases (AKRs) [46]. The
four HSDs described above all belong to the SDR super-
family but a gene from the AKRs was also found to be dif-
ferentially expressed. The aldo-keto reductase family
member 1D1 (AKR1D1) was down-regulated in NLH ani-
mals. AKR1D1 is a liver specific enzyme that regulates the
hormone levels of several steroids [46]. The enzyme has a
5β-reductase activity and is necessary for the catabolism of
aldosterone, cortisol and androgens [50]. Aldosterone,
cortisol and androgens are three of four metabolic com-
pounds formed from pregnenolone, with the fourth com-
pound being androstenone [5]. A role for AKR1D1 in
androstenone catabolism might therefore be possible. We
previously reported up-regulation of the family member
AKR1C4  in the testis of DH and NLH boars [17], but
AKR1D1 has not formerly been associated with porcine
androstenone levels.
Another class of enzymes that regulate the availability of
steroids is the plasma proteins. Binding of plasma protein
is a reversible reaction that has no physiological effect, but
it controls the amount of free drugs and hormones avail-BMC Veterinary Research 2008, 4:29 http://www.biomedcentral.com/1746-6148/4/29
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able to tissues by protecting them from metabolism [51].
Alpha-1-acid glycoprotein (AGP) is an acute phase serum
protein synthesised in the liver and secreted to plasma
where it binds and carries drugs and steroid hormones
[51]. The protein has been shown to interact with CYP3A
and CYP2C19 in humans and to inhibit cytochrome P450
activity [52,53]. It is suggested that serum protein interac-
tion is an important factor for cytochrome P450 mediated
metabolism, and that the interaction is isoform specific
[53]. AGP has also been studied in pigs as a binding factor
of pheromones, but has not been found to bind progester-
one in pig nasal mucosa [54]. AGP has two variants in
humans: orosomucoid 1 and 2 (ORM1 and ORM2) [51].
In this study we found that porcine transcript homolo-
gous to bovine AGP and human ORM1 were significantly
down-regulated in DH and NLH boars. Significant expres-
sion of these genes might explain the inflammatory
response ontology term in figure 2 as these genes have
mostly been described in relation to inflammatory
response. AGP has not been investigated as a binding pro-
tein and transporter for androstenone, but different levels
of androstenone could be related to differences in its
availability through plasma binding by AGP.
Regulatory factors
One of the most significant molecular function terms in
NL was nucleic acid binding. This term includes transcrip-
tion factor binding and several transcription factors were
found to be differentially expressed in this study. The
GATA factor 4 (GATA4) was found to be down-regulated
based on the microarray data, but we were not able to con-
firm this result with rcPCR. Other transcription factors
identified in this study should be further investigated,
including RAR-related orphan receptor A (RORA), tran-
scription elongation factor B3 (TCEB3), nuclear factor I/X
(NFIX), transcription factor 8 (TCF8) and heat shock tran-
scription factor 1 (HSF1). We have previously identified
iron ion binding, ferric ion binding and electron transport
as being associated with levels of androstenone [17], pos-
sibly through interaction with the haem-containing cyto-
chrome P450s. In this study we also found iron ion
binding and electron transport, in addition to haem bind-
ing, to be important pathways, supporting our previous
findings. Cytochrome b5 (CYB5) is involved in electron
transfer to cytochrome P450s and has been proposed as a
candidate gene for androstenone through its interaction
with cytochrome P450 c17 (CYP17) [55]. In this study we
found CYB5 to be down-regulated in NLH boars, however
we previously identified CYB5 as being up-regulated in
the testis of both DH and NLH [17]. Both CYP2E1 and
CYP2A6  have been found to be activated by CYB5  in
humans [56], supporting the down-regulation of CYB5
together with CYP2E1 and CYP2A6 in this study. Up-reg-
ulation in testis and down-regulation in liver might also
support a key regulatory role of CYB5 in both tissues.
Breed differences
Breed differences in boar taint candidate genes have previ-
ously been shown between D and NL [12,17]. Consistent
with these findings, we found breed differences in the
expression profiles of genes involved in both phase I
metabolism and phase II metabolism. However, rcPCR
results might suggest that genes appearing in one breed
can be differentially expressed also in the other breed.
Additional and more comprehensive rcPCR studies are
planned to clarify this. In general, the D breed showed
higher levels of significance compared to the NL breed,
potentially due to the larger contrasts between high and
low androstenone groups in this breed. A number of new
candidate genes have been identified in this study, how-
ever, we do not know their effect on performance and sex-
ual maturation in pig. Additional studies are needed to
investigate potential roles of the genes identified for phe-
notypes related to fertility.
Relationship with skatole
Pigs in this study were selected based on extreme andros-
tenone values. However, levels of androstenone and ska-
tole have previously been found to be highly correlated,
showing genetic correlations of 0.62 for D and 0.36 for NL
[21]. Some of the genes found differentially expressed in
this study have previously been found to be associated
with tryptophan or skatole and this could be explained by
high correlations with androstenone. This might also be
the reason for the significance of GO terms such as aro-
matic amino acid metabolism and catabolism, since the
skatole precursor tryptophan belongs to this family of
amino acids. The tryptophan 2, 3-dioxygenase gene
(TDO2), which oxidises tryptophan, was differentially
expressed in DH. A gene of the FMO family, kynurenine
3-monooxygenase (KMO), was found to be down-regu-
lated in NLH. KMO is involved in tryptophan degradation
and might therefore be interesting in regards to skatole
[57]. The aldehyde oxidase (AOX1) gene was significantly
down-regulated in high androstenone animals of both
breeds and this gene has not previously been associated
with androstenone levels. It has, however, been shown to
play an important role in skatole metabolism in several
species including pigs [58-60].
Conclusion
In this study we compared global gene expression profiles
from the livers of boars with extreme high and low levels
of androstenone from two breeds, Duroc and Norwegian
Landrace. Breed differences are evident for molecular
functions and biological processes involved in metabo-
lism of androstenone, however many of the same genes
are differentially expressed in the two breeds as well.
Genes encoding different oxidising enzymes including the
cytochrome P450 family (CYP2E1, CYP2A19, CYP2C49,
CYP27A1  and  CYP2C33) and the flavin-containingBMC Veterinary Research 2008, 4:29 http://www.biomedcentral.com/1746-6148/4/29
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monooxygenase family (FMO1 and KMO) were signifi-
cantly differentially expressed. Furthermore, genes
involved in conjugation reactions, including the UDP-glu-
curonosyltransferases (UGT1A5, UGT2A1 and UGT2B15),
sulfotransferases (STE), N-acetyltransferases (NAT12) and
glutathione S-transferase were significant, in addition to
genes of the 17β-hydroxysteroid dehydrogenase family
(HSD17B2,  HSD17B4,  HSD17B11  and  HSD17B13),
which are known to regulate availability of active steroids.
We suggest a novel role for plasma proteins including AGP
and ORM1 in regulating availability of androstenone in
pigs. This is the first published microarray experiment
describing liver metabolism of androstenone. A number
of new candidate genes have been identified, both from




Animals used in this study were Duroc (D) and Norwe-
gian Landrace (NL) boars from NORSVIN's three boar
testing stations. The D boars were on average 156 days old
at 100 kg live weight compared to the NL boars that were
on average 143 days old at 100 kg live weight. The boars
were slaughtered on average 14 days later. Tissue samples
from liver were frozen in liquid N2 immediately after
slaughter and stored at -80°C until used for RNA extrac-
tion as described below. Samples from adipose tissue were
collected from the neck at slaughter and stored at -20°C
until used for androstenone measurements. Androsten-
one levels were measured by a modified time-resolved
fluoroimmunoassay at the hormone laboratory, Norwe-
gian School of Veterinary Science (NVH) [61] using an
antiserum produced at NVH [62]. The androstenone
measurements were performed on more than 2500 boars,
and statistical power calculations showed that selecting
animals from each tail of the androstenone distribution
would yield sufficient power to detect differentially
expressed genes with a limited number of arrays. The 30
most extreme boars from each tail of the androstenone
level distribution were therefore selected. Due to poor
RNA quality for two of the samples, 29 samples were sub-
sequently used from each group. 42 of the animals used
were the same individuals as those used in our previous
study examining gene expression in boar testis [17], with
16 being new animals as liver samples were not available
for all of the previously studied animals. Average andros-
tenone levels for the selected boars were 1.17 ppm and
3.22 ppm for NL and D, respectively. (See additional file
5: Androstenone levels). Average values for the groups
were 5.95 ± 2.04 ppm for NL high (NLH), 0.14 ± 0.04
ppm for NL low (NLL), 11.57 ± 3.2 ppm for D high (DH)
and 0.37 ± 0.17 ppm for D low (DL). In order to reduce
family effects, a maximum of two and three half sibs were
chosen from NL and D, respectively. The selected animals
were used for expression profiling by microarrays and for
the following verification of selected genes by rcPCR.
Expression profiling using microarrays
The present work utilises and extends methods described
in our previous microarray experiment [17]. The porcine
cDNA microarrays were produced at the Faculty of Agri-
cultural Sciences, University of Aarhus and contained
27,774 features printed in duplicates. 26,877 features
were PCR products amplified from cDNA clones pro-
duced by the Sino-Danish Porcine Genome Sequencing
project [63,64], and 867 were control features. The 26,877
features represent approximately 20K gene transcripts.
Additional information about the porcine cDNA microar-
ray can be found at NCBIs Gene Expression Omnibus
(GEO, [65]) using the platform accession number
GPL3585. This is a different batch of microarrays com-
pared to the one we used in the testis experiment.
Total RNA was extracted from liver tissue using Qiagen's
RNeasy midi kit according to manufacturer's instruction
(Qiagen, CA, USA). RNA quantity was measured on a
NanoDrop ND-1000 Spectrophotometer (NanoDrop
Technologies, DE, USA) and RNA quality was evaluated
by the 28S:18S rRNA ratio using a RNA 6000 Nano
LabChip® Kit on 2100 Bioanalyzer (Agilent Technologies,
CA, USA). The microarray experiment was conducted as a
common reference design using RNA purified from liver
tissue sampled from an unrelated Danish Landrace ×
Hampshire pig as a reference. Aminoallyl-cDNA was syn-
thesised from 15 μg of total RNA using the SuperScript
indirect cDNA labelling system (Invitrogen Corporation,
CA, USA) and labelled using ARES Alexa Fluor labelling
kits (Molecular Probes, OR, USA). Amino-modified and
fluorescently labelled cDNA was purified using NucleoS-
pin 96 Extract II PCR Clean-up kits (Macherey-Nagel,
Düren, Germany). The individual samples were labelled
with Alexa Fluor 647 and the reference was labelled with
Alexa Fluor 555. "Green" spike-in RNA from the Lucidea
Universal ScoreCard (Amersham Biosciences) was added
to the individuals and "red" spike-in RNA was added to
the reference. Hybridisation was performed in a Discovery
XT hybridisation station (Ventana Discovery Systems, AZ,
USA), followed by manual washing and drying by centrif-
ugation. The microarrays were scanned using a ScanArray
Express scanner (Perkin Elmer Inc., MA, USA) and image
analyses were conducted using GenePix Pro 6 software
(version 6.0.1.26, Molecular Devices Corp., CA, USA).
Statistical analyses were carried out in R version 2.3.1 [66]
using the software package Linear Models for Microarray
Analysis (Limma version 2.7.2) [67-69] which is part of
the Bioconductor package [70]. Log-transformed ratios of
mean foreground intensities (not background corrected)
were print tip loess normalised. The duplicate correlation
function in Limma was used to consider duplicate print-BMC Veterinary Research 2008, 4:29 http://www.biomedcentral.com/1746-6148/4/29
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ing of each feature. To evaluate the analyses, MA-plots (M
= log2594/log2488, A = (log2594 + log2488)/2), image
plots and box plots were constructed using the Limma
tools for visualisation both before and after normalisation
(see additional file 6: Boxplots). To assess differential
expression, Limma uses linear models in combination
with an empirical Bayes method to moderate the standard
errors of the estimated log-fold changes [68]. The nominal
p-values were corrected for multiple testing by false dis-
covery rates (FDR) using Benjamini and Hochberg
approach [71]. Each of the groups DH, DL, NLH and NLL
animals were hybridised in individual batches, causing
some confounding between androstenone levels and
hybridisation batch. However, as neither boxplots nor
MA-plots were found to differ between hybridisation
batches, it was assumed that the impact of hybridisation
batch on the obtained data can be ignored. The top 1% of
the genes was considered for further analyses. The array
features were mapped to a LocusLink identifier and an
annotation package was built using the Bioconductor
package AnnBuilder (version 1.9.14). GO terms (p < 0.01
and more than 10 significant genes) were analysed for
overrepresentation using the GOHyperG function of the
Bioconductor package GOstats (version 1.6.0) [72,73].
More detailed descriptions of the microarray experiments
are available at the GEO database through the series acces-
sion number GSE 11073.
Quantitative real competitive PCR analysis
A real competitive PCR (rcPCR) gene expression analysis
was used to verify a subset of the results from the microar-
ray study. Quantitative Gene Expression (QGE) was per-
formed using MassARRAY methodology and the iPLEX
protocol (Sequenom, CA, USA). Total RNA was isolated
from liver using an automatic DNA/RNA extractor
(BioRobot M48 workstation; Qiagen; CA, USA). Total
RNA was treated with TURBO DNA-free™ (Ambion,
Huntingdon, UK) for removal of contaminating DNA and
first strand cDNA synthesis was conducted on 0.5 μg total
RNA using SuperScript™-II Rnase H- Reverse Transcriptase
(Invitrogen, Carlsbad, CA, USA). Assays for the genes
included in this study (See additional file 7: Gene tran-
scripts included in the rcPCR analyses) were designed and
multiplexed into a single reaction using MassARRAY QGE
Assay Design software (Sequenom, CA, USA). The com-
petitor, a synthetic DNA molecule matching the targeted
cDNA sequence at all positions except for one single base,
served as an internal standard for each transcript. A 10-
fold competitor dilution was initially used over a wide
range of concentrations to determine an approximate
equivalence point. Following this, a 7-fold dilution of
competitor from 4.04 × 10-11 to 1.43 × 10-19 was used to
achieve accurate quantification. The cDNA and competi-
tor were co-amplified in the same PCR reaction with the
following conditions: 95°C for 15 minutes, 45 cycles each
of 95°C for 20 second, 56°C for 30 seconds and 72°C for
1 minute, and 72°C for 3 minutes. A clean-up step was
performed to remove unincorporated nucleotides. The
iPLEX reaction cocktail mix and PCR conditions were
according to manufacturer's instructions [74]. Parallel
PCR reactions were performed for all samples and the
products were printed with two replicates on a Spectro-
CHIP. The primer extension reaction uses PCR products as
templates and generates distinct mass signals for compet-
itor and cDNA-derived products. Mass spectrometric anal-
ysis generated signals from which peak areas were
calculated. Gene expression levels were analysed using
TITAN software version 1.0–13 [75,76] that runs in the R
statistical environment. Raw data from the Genotype Ana-
lyzer Software (Sequenom) were imported into TITAN
and analysed using the default values of linear least
squares polynomial regression and 4000 bootstrap repli-
cates. cDNA concentrations were corrected with respect to
the housekeeping gene (TFRC), and p-values and confi-
dence intervals for fold changes were calculated.
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